TerminatedNot Applicable

Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver Transplantation

Stopped: in order to get sufficient follow-up period and judged to be gather enough subjects

511 participantsStarted 2012-01-01

Plain-language summary

This retrospective cohort study investigates the long-term outcomes of ABO-incompatible (ABO-I) versus ABO-compatible (ABO-C) living donor liver transplantation (LDLT). A total of 511 patients at a single high-volume transplant center in Korea. The study aims to compare overall survival and the incidence of biliary complications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All adult patients who underwent LDLT at the study center from 2012 to 2022 Exclusion Criteria: * Pediatric patients, deceased donor recipients, multi-organ transplants.

What they're measuring

Incidence of biliary complications

Timeframe: within 10 years post-transplantation

Trial details

NCT IDNCT07105085

SponsorSeoung Hoon Kim

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Liver Transplantation trials